PureTech Health (PRTC)

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

O preço da ação PureTech Health plc American Depositary Shares (PRTC) hoje é de $ 17,90, refletindo uma movimentação de 0,00% desde que o mercado abriu. A capitalização de mercado da empresa é de $ 432,61 mi, com um volume comercial diário de $ 2,00 ações. O preço de fechamento anterior foi $ 17,90.

Vamos começar? Siga os passos abaixo ou leia nosso guia sobre como comprar PureTech Health ações na Kraken a partir de US$ 10.